CSIMarket
 
Bright Minds Biosciences Inc   (NASDAQ: DRUG)
 

Bright Minds Biosciences Inc's Customers Performance

DRUG



 
DRUG's Source of Revenues

List of DRUG Customers




for the same period Bright Minds Biosciences Inc

List of DRUG Customers





Bright Minds Biosciences Inc's Comment on Sales, Marketing and Customers





  News about Bright Minds Biosciences Inc Contracts

BMB-201 A New Hope in Pain Management Amidst Financial Struggles

In the fast-paced world of pharmaceutical innovation, Bright Minds Biosciences Inc. stands at a crucial juncture as it unveils promising data on its proprietary compound, BMB-201. This mixed agonist of the 5-HT2C and 5-HT2A receptors has shown remarkable similarities in efficacy to morphine within various preclinical pain models. This breakthrough may offer a new avenue for treatment in both acute and chronic pain management without falling into the pitfalls associated with traditional opioid therapies.Opioids, particularly morphine, have long been the cornerstone of pain relief. However, the opioid crisis has underscored the urgent need for alternative therapies that can provide similar analgesic effects wi...












DRUG's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Bright Minds Biosciences Inc 438.54 0.00 -2.15 57
SUBTOTAL 0.00 0.00 0.00 -

Sources: Bright Minds Biosciences Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Bright Minds Biosciences Inc’s corporate clients.
For your research, we’ve provided 9 tables on Bright Minds Biosciences Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.